Mouse Anti-HMGN5 Antibody (2E6) (CBMAB-0488-YC)

Mou, J., Huang, M., Wang, F., Xu, X., Xie, H., Lu, H., ... & Ren, J. (2022). HMGN5 escorts oncogenic STAT3 signaling by regulating the chromatin landscape in breast cancer tumorigenesis. Molecular Cancer Research, 20(12), 1724-1738.

Jin, J., Xu, B., Hu, Z., & He, X. (2022). Circular RNA circTADA2A promotes the proliferation, invasion, and migration of non-small cell lung cancer cells via the miR-450b-3p/HMGN5 signaling pathway. Translational Cancer Research, 11(1), 242.

Yao, K., He, L., Gan, Y., Liu, J., Tang, J., Long, Z., & Tan, J. (2020). HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27. Aging (Albany NY), 12(8), 7282.

Ma, Q., Wang, X., Wang, H., Song, W., Wang, Q., & Wang, J. (2020). HMGN5 silencing suppresses cell biological progression via AKT/MAPK pathway in human glioblastoma cells. BioMed Research International, 2020.

Xu, E., Ji, Z., Jiang, H., Lin, T., Ma, J., & Zhou, X. (2019). Hypoxia-inducible factor 1A upregulates HMGN5 by increasing the expression of GATA1 and plays a role in osteosarcoma metastasis. BioMed Research International, 2019.

Zhao, J., Wang, Y., & Wu, X. (2018). HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma. Oncology Letters, 16(3), 4013-4019.

Wu, J., & Wang, J. (2018). HMGN5 expression in bladder cancer tissue and its role on prognosis. Eur Rev Med Pharmacol Sci, 22(4), 970-975.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols